Sridhar Chaganti

Colleges, School and Institutes

View graph of relations

Most downloaded publications

Greatly reduced risk of EBV reactivation in Rituximab-experienced recipients of Alemtuzumab-conditioned allogeneic HSCT
David Burns, Emma Martin, Andrew Bell, Paul Moss, Charles Craddock, Christopher Fox & Sridhar Chaganti, Jun 2016, In: Bone Marrow Transplantation. 51, 6, p. 825-832

Research output: Contribution to journal › Article › peer-review

164 downloads

Recent publications

Greatly reduced risk of EBV reactivation in Rituximab-experienced recipients of Alemtuzumab-conditioned allogeneic HSCT
David Burns, Emma Martin, Andrew Bell, Paul Moss, Charles Craddock, Christopher Fox & Sridhar Chaganti, Jun 2016, In: Bone Marrow Transplantation. 51, 6, p. 825-832

Research output: Contribution to journal › Article › peer-review

Memory B cell reconstitution following allogeneic haematopoietic stem cell transplantation is an EBV-associated transformation event
David Burns, Rosemary Tierney, Claire Shannon-Lowe, Charlotte Inman, Christopher Fox, Sridhar Chaganti, Charles Craddock, Paul Moss, Alan Rickinson, Martin Rowe & Andrew Bell, 17 Dec 2015, In: Blood. 126, 25, p. 2665-2675 11 p.

Research output: Contribution to journal › Article › peer-review

Transfusion in CMV seronegative T -depleted allogeneic stem cell transplant recipients with CMV -unselected blood components results in zero CMV transmissions in the era of universal lekocyte reduction: a U.K dual centre experience.
Charles Craddock & Sridhar Chaganti, 2015, In: Transfusion Medicine.

Research output: Contribution to journal › Article › peer-review

View all (10)